Cara Therapeutics, Inc.
CARA
Revenue
991.00k
▼-1.14M▼-53.58%
3 Months ChangeAssets
72.50M
▼-17.60M▼-19.54%
3 Months ChangeLiabilities
60.90M
▲601.00k▲0.9967%
3 Months ChangeFree Cash Flow
-31.29M
▼-5.72M▼-22.38%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001558370-24-012231
2024-08-01
Form 8-K
ID: 0001104659-24-084911
2024-06-18
Form 8-K
ID: 0001104659-24-072821
2024-06-12
Form 8-K
ID: 0001104659-24-070914
2024-06-07
Form 8-K
ID: 0001104659-24-069625
2024-05-13
Form 10-Q
ID: 0001558370-24-007964
2024-05-13
Form 8-K
ID: 0001104659-24-060529
2024-03-22
Form 8-K
ID: 0001104659-24-037855
2024-03-04
Form 8-K
ID: 0001104659-24-030494
2024-02-02
Form 8-K
ID: 0001104659-24-010123